Header cover image

Taiwanese (TAIEX) Healthcare Sector Analysis

UpdatedFeb 27, 2024
DataAggregated Company Financials
Companies197
  • 7D1.9%
  • 3M2.9%
  • 1Y-4.3%
  • YTD3.8%

The Healthcare industry has been flat over the last week, but Lumosa Therapeutics has lost 13%. Unfortunately though, the industry is down 6.2% over the past 12 months. As for the next few years, earnings are expected to grow by 57% per annum.

Sector Valuation and Performance

Has the Taiwanese Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 Feb 2024NT$1.5tNT$225.8bNT$6.5b25.8x229.6x6.6x
Fri, 26 Jan 2024NT$1.4tNT$225.0bNT$5.9b25x232.4x6.1x
Sun, 24 Dec 2023NT$1.4tNT$224.7bNT$5.9b25.5x239x6.2x
Tue, 21 Nov 2023NT$1.4tNT$224.7bNT$6.6b24.9x210.8x6.2x
Thu, 19 Oct 2023NT$1.3tNT$225.3bNT$8.3b24.2x158.1x5.8x
Sat, 16 Sep 2023NT$1.4tNT$225.2bNT$8.2b25.9x168.5x6.2x
Mon, 14 Aug 2023NT$1.4tNT$221.8bNT$7.0b25.2x197.2x6.2x
Wed, 12 Jul 2023NT$1.4tNT$226.5bNT$11.5b25.4x122.7x6.3x
Fri, 09 Jun 2023NT$1.4tNT$226.1bNT$11.6b24.8x123x6.3x
Sun, 07 May 2023NT$1.5tNT$220.1bNT$12.0b25.2x123.6x6.8x
Tue, 04 Apr 2023NT$1.4tNT$221.6bNT$13.1b22.1x108.8x6.4x
Thu, 02 Mar 2023NT$1.5tNT$214.8bNT$13.6b21.5x107.2x6.8x
Sat, 28 Jan 2023NT$1.3tNT$214.5bNT$13.8b20.1x94.3x6.1x
Mon, 26 Dec 2022NT$1.3tNT$214.5bNT$13.8b20.2x95x6.1x
Wed, 23 Nov 2022NT$1.3tNT$214.4bNT$13.9b17.1x91.2x5.9x
Fri, 21 Oct 2022NT$1.1tNT$207.4bNT$10.8b18.4x106.6x5.5x
Sun, 18 Sep 2022NT$1.4tNT$207.4bNT$10.8b21.4x131.3x6.8x
Tue, 16 Aug 2022NT$1.3tNT$206.0bNT$11.7b20.4x107.3x6.1x
Thu, 14 Jul 2022NT$1.2tNT$199.0bNT$9.8b21.7x121x5.9x
Sat, 11 Jun 2022NT$1.2tNT$207.9bNT$10.7b22.5x114.9x5.9x
Mon, 09 May 2022NT$1.2tNT$206.0bNT$12.0b23x102.6x6x
Wed, 06 Apr 2022NT$1.3tNT$204.7bNT$12.3b23.6x103x6.2x
Fri, 04 Mar 2022NT$1.3tNT$202.0bNT$14.4b22.8x86.9x6.2x
Sun, 30 Jan 2022NT$1.1tNT$202.1bNT$14.1b21.8x79.8x5.6x
Tue, 28 Dec 2021NT$1.2tNT$202.1bNT$14.1b21.8x81.9x5.7x
Thu, 25 Nov 2021NT$1.1tNT$202.1bNT$14.1b20.5x77x5.4x
Sat, 23 Oct 2021NT$1.0tNT$197.1bNT$13.9b20.8x73.5x5.2x
Mon, 20 Sep 2021NT$1.0tNT$197.1bNT$14.2b21.6x74x5.3x
Wed, 18 Aug 2021NT$1.0tNT$197.0bNT$14.1b21.4x73.5x5.3x
Wed, 02 Jun 2021NT$1.1tNT$191.4bNT$14.8b20.9x71.9x5.6x
Sat, 06 Mar 2021NT$940.9bNT$186.1bNT$9.7b19.1x96.8x5.1x
Price to Earnings Ratio

96.8x


Total Market Cap: NT$940.9bTotal Earnings: NT$9.7bTotal Revenue: NT$186.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Sector Price to Earnings3Y Average 116.1x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 225x which is higher than its 3-year average PE of 115x.
  • The industry is trading close to its 3-year average PS ratio of 5.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 13% per year over the last three years.
  • Meanwhile revenues for these companies have grown 6.7% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare sector?

TW Market1.61%
Healthcare1.93%
Biotech2.48%
Healthcare Services2.01%
Pharma1.99%
Healthtech1.24%
Life Sciences1.00%
Medical Equipment0.82%
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 59.2x.
    • Analysts are expecting annual earnings growth of 35.5%, which is higher than its past year's earnings decline of 10.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 117% over the next 5 years.
  • This is better than its past earnings decline of 12% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 19% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1795 Lotus PharmaceuticalNT$296.007.4%
+NT$5.4b
5.3%PE20.2x
4147 TaiMed BiologicsNT$114.0018.4%
+NT$4.5b
43.2%PS43.7x
6472 Bora PharmaceuticalsNT$672.004.8%
+NT$3.2b
73.5%PE23.7x
6919 Caliway BiopharmaceuticalsNT$513.004.6%
+NT$3.1b
125.0%PS2554.3x
6535 Lumosa TherapeuticsNT$160.0010.3%
+NT$2.5b
273.0%PS499.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6446

NT$324.00

PharmaEssentia

7D

-1.2%

1Y

-35.7%

4147

NT$114.00

TaiMed Biologics

7D

18.4%

1Y

43.2%

6919

NT$513.00

Caliway Biopharmaceuticals

7D

4.6%

1Y

125.0%

6932

NT$15.80

Mercury Biopharmaceutical

7D

-6.5%

1Y

-41.5%

6586

NT$63.90

CHO Pharma

7D

-3.5%

1Y

-50.7%

6875

NT$117.00

Pharmosa Biopharm

7D

12.0%

1Y

32.8%

4771

NT$280.00

Vizionfocus

7D

-4.4%

1Y

84.8%

6785

NT$432.00

Alar Pharmaceuticals

7D

-2.3%

1Y

114.9%

6535

NT$160.00

Lumosa Therapeutics

7D

10.3%

1Y

273.0%

1795

NT$296.00

Lotus Pharmaceutical

7D

7.4%

1Y

5.3%

6491

NT$402.50

Pegavision

7D

2.9%

1Y

-10.2%

6712

NT$220.50

Ever Supreme Bio Technology

7D

11.4%

1Y

13.3%

6472

NT$672.00

Bora Pharmaceuticals

7D

4.8%

1Y

73.5%

6782

NT$248.50

Visco Vision

7D

-5.0%

1Y

-33.7%

6550

NT$70.30

Polaris Group

7D

-2.9%

1Y

-29.1%

6617

NT$203.00

Gongwin Biopharm Holdings

7D

-4.7%

1Y

-34.4%